qXR-CTR vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
qXR-CTR
by Qure.ai Technologies
VS
Cardiomo
by Cardiomo, Inc.

AI Verdict

qXR-CTR and Cardiomo are adjacent tools in cardiology AI, addressing different aspects of heart health. qXR-CTR focuses on automated cardiothoracic ratio assessment from chest X-rays for heart size and potential heart failure risk, serving as a diagnostic aid for clinicians. Cardiomo, on the other hand, provides continuous remote heart health monitoring through a wearable device, offering real-time alerts for cardiovascular diseases to users and caregivers.

Choose qXR-CTR if…

Choose qXR-CTR if your primary need is an automated, AI-powered solution for rapidly assessing heart size and potential heart failure risk directly from chest X-ray images. This tool is ideal for radiology departments and cardiology practices seeking to streamline initial diagnostic workflows and enhance the efficiency of cardiothoracic ratio measurements. It is particularly well-suited for high-volume environments where quick, consistent, and FDA-cleared analysis of existing imaging data is crucial.

View qXR-CTR →

Choose Cardiomo if…

Choose Cardiomo if your focus is on continuous, remote, and proactive heart health monitoring for patients, especially those at risk of cardiovascular diseases or requiring ongoing oversight. This wearable device and AI platform are best for clinicians and caregivers who need real-time vital sign data, AI-powered alerts for potential cardiovascular events, and fall detection capabilities. It is particularly valuable for managing chronic conditions, supporting geriatric care, and enabling timely interventions through remote patient monitoring.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature qXR-CTR Cardiomo
Pricing Contact for pricing Contact for pricing
Deployment Cloud, on-premise, hybrid Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiomo

Cardiomo, with its wearable patch and mobile app, appears to offer a more direct and user-friendly experience for continuous personal health monitoring. qXR-CTR, while providing automated analysis, is primarily a software tool for healthcare professionals interpreting X-rays, implying a different user base and interaction model. Cardiomo is described as 'highly reliable, flexible, practical and user-friendly' for continuous heart monitoring.

Clinical Value

Cardiomo

Cardiomo's continuous vital sign monitoring and AI-powered disease detection with real-time alerts offer direct and immediate clinical value for early detection and intervention in cardiovascular diseases. qXR-CTR provides automated CTR assessment, which is a valuable diagnostic aid, but Cardiomo's continuous monitoring and alert system has the potential for more proactive and life-saving interventions. Cardiomo aims to detect signs of a heart attack and alert the user, with the potential to save lives by detecting conditions in time.

Pricing & Value

Tie

Both tools currently list their pricing as 'contact for pricing,' making a direct comparison of value difficult. While Cardiomo previously had public pricing, it is no longer available, and neither company offers transparent pricing information at this time.

Enterprise Readiness

qXR-CTR

qXR-CTR offers flexible deployment options (Cloud, on-premise, hybrid) and is designed for use by hospitals and clinics, indicating a strong focus on enterprise integration and scalability within existing healthcare IT infrastructures. Cardiomo, while HIPAA compliant and cloud-based, is centered around a wearable device, which may present different integration challenges for large-scale enterprise deployment compared to a software-only solution.

Innovation

Cardiomo

Cardiomo's integration of a medical-grade wearable device with continuous vital sign monitoring and AI-powered real-time alerts for cardiovascular events represents a significant innovation in remote patient monitoring. While qXR-CTR's automated CTR measurement is innovative for radiology workflows, Cardiomo's approach to proactive, continuous, and remote patient engagement pushes the boundaries of traditional healthcare delivery.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details regarding the level of customer support, availability of documentation, or training resources for either qXR-CTR or Cardiomo. Therefore, it is not possible to determine a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature qXR-CTR Cardiomo
Name qXR-CTR Cardiomo
Company Qure.ai Technologies Cardiomo, Inc.
Description qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.
Tagline AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment. A medical-grade wearable device that monitors vital signs and uses an AI engine to detect cardiovascular diseases and provide life-saving alerts.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring qXR-CTR and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

qXR-CTR is designed to integrate seamlessly into existing radiology workflows, providing annotated X-rays and structured reports in DICOM and JSON formats. It can connect with PACS, modalities, and the Qure.ai App, and offers integration partners like GE Healthcare and Philips Healthcare. Cardiomo offers a RESTful API, webhooks, and pre-built integrations for platforms like Epic and Cerner, aiming for seamless connection with existing systems. Both types of tools generally aim to integrate with EHRs to improve monitoring and detection of patient risk factors.
qXR-CTR automates the measurement of the cardiothoracic ratio (CTR) from chest X-rays, which aids in assessing heart size and potential heart failure risk. Clinical studies have shown its accuracy in measuring cardiac and thoracic diameters, with a mean absolute error of 5.66 mm and 4.04 mm respectively. Cardiomo's medical-grade wearable device and AI platform are designed for continuous heart health monitoring, detecting cardiovascular diseases and providing timely alerts. Cardiomo claims 99.63% accuracy in detecting cardiac events. Medical-grade wearable devices, in general, are validated at 99.2% accuracy against clinical gold standards for key health metrics.
qXR-CTR is suitable for physicians in inpatient and outpatient settings to automate CTR assessment on chest radiographs, assisting in the diagnosis and monitoring of heart conditions and identifying heart failure risk. Cardiomo is designed for continuous and remote heart health monitoring, detecting cardiovascular diseases, and providing timely alerts to users and caregivers. It is particularly aimed at individuals aged 45 and above, especially those with existing heart issues, and can be used for preventive care and monitoring of loved ones.
qXR-CTR provides audit logs as one of its security features. Cardiomo also logs and audits all access to data, with RBAC ensuring only authorized personnel can access information. Comprehensive audit trails are essential for HIPAA compliance, allowing tracking of each user who accesses patient data.
For qXR-CTR, its deployment options (cloud, on-premise, hybrid) and multi-region/cloud data residency with on-premise deployment options suggest flexibility for multi-site rollouts. Cardiomo's cloud-based platform with a wearable device and mobile app inherently supports remote monitoring, which can facilitate multi-site deployments. In general, multi-location cardiology practices require shared protocols, unified billing, and per-site workflow configuration that can be maintained without duplicating administrative overhead.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring qXR-CTR or Cardiomo

Backers

Who funded each tool's parent company.

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.